HilleVax Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
HLVX is expected to report earnings to fall 47.83% to -11 cents per share on November 06
Q3'25
Est.
$-0.12
Q2'25
Beat
by $0.06
Q4'24
Missed
by $0.37
Q3'24
Missed
by $0.10
Q2'24
Missed
by $0.05
The last earnings report on August 06 showed earnings per share of -23 cents, beating the estimate of -28 cents. With 344.24K shares outstanding, the current market capitalization sits at 103.51M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HLVX showed earnings on August 06, 2025. You can read more about the earnings report here.